カテゴリ： その他産業, 世界, QYResearch

生化学ベフェンスの世界市場2023年：炭疽菌、天然痘、ボツリヌス中毒症、放射線・核、その他

■ 英語タイトル：Global Biochemical Befense Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8523）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8523
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：新技術
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥429,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥643,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥858,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[生化学ベフェンスの世界市場2023年：炭疽菌、天然痘、ボツリヌス中毒症、放射線・核、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は生化学ベフェンスのグローバル市場について調査・分析し、世界の生化学ベフェンス市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（炭疽菌、天然痘、ボツリヌス中毒症、放射線・核、その他）、用途別セグメント分析（国防、軍事）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Emergent Biosolutions、Hytest、GSK、Sanofi、PharmAthene、Bavarian Nordic、SIGA Technologies、Arbutus Biopharma、DynPort Vaccine、Xoma Corporation、Ichor Medical Systems、Aeolus Pharmaceuticals、Achaogen、Elusys Therapeutics、Dynavax Technologies、Cleveland BioLabs、Soligenix、Alnylam Pharmaceuticalsなどが含まれています。生化学ベフェンスのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、生化学ベフェンス市場規模を算出する際に考慮しました。

・生化学ベフェンス市場の概要
- 生化学ベフェンスの種類別セグメント
- 世界の生化学ベフェンス市場規模：タイプ別分析（炭疽菌、天然痘、ボツリヌス中毒症、放射線・核、その他）
- 生化学ベフェンスの用途別セグメント
- 世界の生化学ベフェンス市場規模：用途別分析（国防、軍事）
- 世界の生化学ベフェンス市場規模予測（2018年-2029年）

・生化学ベフェンス市場の成長トレンド
- 生化学ベフェンスの地域別市場規模（2018年-2029年）
- 生化学ベフェンス市場ダイナミクス
- 生化学ベフェンスの業界動向
- 生化学ベフェンス市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：炭疽菌、天然痘、ボツリヌス中毒症、放射線・核、その他
- 世界の生化学ベフェンスのタイプ別市場規模（2018年-2023年）
- 世界の生化学ベフェンスのタイプ別市場規模（2024年-2029年）

・用途別セグメント：国防、軍事
- 世界の生化学ベフェンスの用途別市場規模（2018年-2023年）
- 世界の生化学ベフェンスの用途別市場規模（2024年-2029年）

・生化学ベフェンスの地域別市場規模
- 北米の生化学ベフェンス市場規模（2018年-2029年）
- 米国の生化学ベフェンス市場規模（2018年-2029年）
- ヨーロッパの生化学ベフェンス市場規模（2018年-2029年）
- アジア太平洋の生化学ベフェンス市場規模（2018年-2029年）
- 中国の生化学ベフェンス市場規模（2018年-2029年）
- 日本の生化学ベフェンス市場規模（2018年-2029年）
- 韓国の生化学ベフェンス市場規模（2018年-2029年）
- インドの生化学ベフェンス市場規模（2018年-2029年）
- オーストラリアの生化学ベフェンス市場規模（2018年-2029年）
- 中南米の生化学ベフェンス市場規模（2018年-2029年）
- 中東・アフリカの生化学ベフェンス市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Emergent Biosolutions、Hytest、GSK、Sanofi、PharmAthene、Bavarian Nordic、SIGA Technologies、Arbutus Biopharma、DynPort Vaccine、Xoma Corporation、Ichor Medical Systems、Aeolus Pharmaceuticals、Achaogen、Elusys Therapeutics、Dynavax Technologies、Cleveland BioLabs、Soligenix、Alnylam Pharmaceuticals

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Biochemical Befense market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Biochemical Befense is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Biochemical Befense is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Biochemical Befense in National Defense is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Biochemical Befense include Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma and DynPort Vaccine, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biochemical Befense, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biochemical Befense.
The Biochemical Befense market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biochemical Befense market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biochemical Befense companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Segment by Type
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Other
Segment by Application
National Defense
Military
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biochemical Befense companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biochemical Befense Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Anthrax
1.2.3 Smallpox
1.2.4 Botulism
1.2.5 Radiation/Nuclear
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biochemical Befense Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 National Defense
1.3.3 Military
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biochemical Befense Market Perspective (2018-2029)
2.2 Biochemical Befense Growth Trends by Region
2.2.1 Global Biochemical Befense Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biochemical Befense Historic Market Size by Region (2018-2023)
2.2.3 Biochemical Befense Forecasted Market Size by Region (2024-2029)
2.3 Biochemical Befense Market Dynamics
2.3.1 Biochemical Befense Industry Trends
2.3.2 Biochemical Befense Market Drivers
2.3.3 Biochemical Befense Market Challenges
2.3.4 Biochemical Befense Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biochemical Befense Players by Revenue
3.1.1 Global Top Biochemical Befense Players by Revenue (2018-2023)
3.1.2 Global Biochemical Befense Revenue Market Share by Players (2018-2023)
3.2 Global Biochemical Befense Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biochemical Befense Revenue
3.4 Global Biochemical Befense Market Concentration Ratio
3.4.1 Global Biochemical Befense Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biochemical Befense Revenue in 2022
3.5 Biochemical Befense Key Players Head office and Area Served
3.6 Key Players Biochemical Befense Product Solution and Service
3.7 Date of Enter into Biochemical Befense Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biochemical Befense Breakdown Data by Type
4.1 Global Biochemical Befense Historic Market Size by Type (2018-2023)
4.2 Global Biochemical Befense Forecasted Market Size by Type (2024-2029)
5 Biochemical Befense Breakdown Data by Application
5.1 Global Biochemical Befense Historic Market Size by Application (2018-2023)
5.2 Global Biochemical Befense Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biochemical Befense Market Size (2018-2029)
6.2 North America Biochemical Befense Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biochemical Befense Market Size by Country (2018-2023)
6.4 North America Biochemical Befense Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biochemical Befense Market Size (2018-2029)
7.2 Europe Biochemical Befense Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biochemical Befense Market Size by Country (2018-2023)
7.4 Europe Biochemical Befense Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biochemical Befense Market Size (2018-2029)
8.2 Asia-Pacific Biochemical Befense Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biochemical Befense Market Size by Region (2018-2023)
8.4 Asia-Pacific Biochemical Befense Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biochemical Befense Market Size (2018-2029)
9.2 Latin America Biochemical Befense Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biochemical Befense Market Size by Country (2018-2023)
9.4 Latin America Biochemical Befense Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biochemical Befense Market Size (2018-2029)
10.2 Middle East & Africa Biochemical Befense Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biochemical Befense Market Size by Country (2018-2023)
10.4 Middle East & Africa Biochemical Befense Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emergent Biosolutions
11.1.1 Emergent Biosolutions Company Detail
11.1.2 Emergent Biosolutions Business Overview
11.1.3 Emergent Biosolutions Biochemical Befense Introduction
11.1.4 Emergent Biosolutions Revenue in Biochemical Befense Business (2018-2023)
11.1.5 Emergent Biosolutions Recent Development
11.2 Hytest
11.2.1 Hytest Company Detail
11.2.2 Hytest Business Overview
11.2.3 Hytest Biochemical Befense Introduction
11.2.4 Hytest Revenue in Biochemical Befense Business (2018-2023)
11.2.5 Hytest Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Biochemical Befense Introduction
11.3.4 GSK Revenue in Biochemical Befense Business (2018-2023)
11.3.5 GSK Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Biochemical Befense Introduction
11.4.4 Sanofi Revenue in Biochemical Befense Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 PharmAthene
11.5.1 PharmAthene Company Detail
11.5.2 PharmAthene Business Overview
11.5.3 PharmAthene Biochemical Befense Introduction
11.5.4 PharmAthene Revenue in Biochemical Befense Business (2018-2023)
11.5.5 PharmAthene Recent Development
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Detail
11.6.2 Bavarian Nordic Business Overview
11.6.3 Bavarian Nordic Biochemical Befense Introduction
11.6.4 Bavarian Nordic Revenue in Biochemical Befense Business (2018-2023)
11.6.5 Bavarian Nordic Recent Development
11.7 SIGA Technologies
11.7.1 SIGA Technologies Company Detail
11.7.2 SIGA Technologies Business Overview
11.7.3 SIGA Technologies Biochemical Befense Introduction
11.7.4 SIGA Technologies Revenue in Biochemical Befense Business (2018-2023)
11.7.5 SIGA Technologies Recent Development
11.8 Arbutus Biopharma
11.8.1 Arbutus Biopharma Company Detail
11.8.2 Arbutus Biopharma Business Overview
11.8.3 Arbutus Biopharma Biochemical Befense Introduction
11.8.4 Arbutus Biopharma Revenue in Biochemical Befense Business (2018-2023)
11.8.5 Arbutus Biopharma Recent Development
11.9 DynPort Vaccine
11.9.1 DynPort Vaccine Company Detail
11.9.2 DynPort Vaccine Business Overview
11.9.3 DynPort Vaccine Biochemical Befense Introduction
11.9.4 DynPort Vaccine Revenue in Biochemical Befense Business (2018-2023)
11.9.5 DynPort Vaccine Recent Development
11.10 Xoma Corporation
11.10.1 Xoma Corporation Company Detail
11.10.2 Xoma Corporation Business Overview
11.10.3 Xoma Corporation Biochemical Befense Introduction
11.10.4 Xoma Corporation Revenue in Biochemical Befense Business (2018-2023)
11.10.5 Xoma Corporation Recent Development
11.11 Ichor Medical Systems
11.11.1 Ichor Medical Systems Company Detail
11.11.2 Ichor Medical Systems Business Overview
11.11.3 Ichor Medical Systems Biochemical Befense Introduction
11.11.4 Ichor Medical Systems Revenue in Biochemical Befense Business (2018-2023)
11.11.5 Ichor Medical Systems Recent Development
11.12 Aeolus Pharmaceuticals
11.12.1 Aeolus Pharmaceuticals Company Detail
11.12.2 Aeolus Pharmaceuticals Business Overview
11.12.3 Aeolus Pharmaceuticals Biochemical Befense Introduction
11.12.4 Aeolus Pharmaceuticals Revenue in Biochemical Befense Business (2018-2023)
11.12.5 Aeolus Pharmaceuticals Recent Development
11.13 Achaogen
11.13.1 Achaogen Company Detail
11.13.2 Achaogen Business Overview
11.13.3 Achaogen Biochemical Befense Introduction
11.13.4 Achaogen Revenue in Biochemical Befense Business (2018-2023)
11.13.5 Achaogen Recent Development
11.14 Elusys Therapeutics
11.14.1 Elusys Therapeutics Company Detail
11.14.2 Elusys Therapeutics Business Overview
11.14.3 Elusys Therapeutics Biochemical Befense Introduction
11.14.4 Elusys Therapeutics Revenue in Biochemical Befense Business (2018-2023)
11.14.5 Elusys Therapeutics Recent Development
11.15 Dynavax Technologies
11.15.1 Dynavax Technologies Company Detail
11.15.2 Dynavax Technologies Business Overview
11.15.3 Dynavax Technologies Biochemical Befense Introduction
11.15.4 Dynavax Technologies Revenue in Biochemical Befense Business (2018-2023)
11.15.5 Dynavax Technologies Recent Development
11.16 Cleveland BioLabs
11.16.1 Cleveland BioLabs Company Detail
11.16.2 Cleveland BioLabs Business Overview
11.16.3 Cleveland BioLabs Biochemical Befense Introduction
11.16.4 Cleveland BioLabs Revenue in Biochemical Befense Business (2018-2023)
11.16.5 Cleveland BioLabs Recent Development
11.17 Soligenix
11.17.1 Soligenix Company Detail
11.17.2 Soligenix Business Overview
11.17.3 Soligenix Biochemical Befense Introduction
11.17.4 Soligenix Revenue in Biochemical Befense Business (2018-2023)
11.17.5 Soligenix Recent Development
11.18 Alnylam Pharmaceuticals
11.18.1 Alnylam Pharmaceuticals Company Detail
11.18.2 Alnylam Pharmaceuticals Business Overview
11.18.3 Alnylam Pharmaceuticals Biochemical Befense Introduction
11.18.4 Alnylam Pharmaceuticals Revenue in Biochemical Befense Business (2018-2023)
11.18.5 Alnylam Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Biochemical Befense Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Anthrax
Table 3. Key Players of Smallpox
Table 4. Key Players of Botulism
Table 5. Key Players of Radiation/Nuclear
Table 6. Key Players of Other
Table 7. Global Biochemical Befense Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Biochemical Befense Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Biochemical Befense Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Biochemical Befense Market Share by Region (2018-2023)
Table 11. Global Biochemical Befense Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Biochemical Befense Market Share by Region (2024-2029)
Table 13. Biochemical Befense Market Trends
Table 14. Biochemical Befense Market Drivers
Table 15. Biochemical Befense Market Challenges
Table 16. Biochemical Befense Market Restraints
Table 17. Global Biochemical Befense Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Biochemical Befense Market Share by Players (2018-2023)
Table 19. Global Top Biochemical Befense Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biochemical Befense as of 2022)
Table 20. Ranking of Global Top Biochemical Befense Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Biochemical Befense Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biochemical Befense Product Solution and Service
Table 24. Date of Enter into Biochemical Befense Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biochemical Befense Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Biochemical Befense Revenue Market Share by Type (2018-2023)
Table 28. Global Biochemical Befense Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Biochemical Befense Revenue Market Share by Type (2024-2029)
Table 30. Global Biochemical Befense Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Biochemical Befense Revenue Market Share by Application (2018-2023)
Table 32. Global Biochemical Befense Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Biochemical Befense Revenue Market Share by Application (2024-2029)
Table 34. North America Biochemical Befense Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Biochemical Befense Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Biochemical Befense Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Biochemical Befense Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Biochemical Befense Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Biochemical Befense Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Biochemical Befense Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Biochemical Befense Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Biochemical Befense Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Biochemical Befense Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Biochemical Befense Market Size by Country (2024-2029) & (US$ Million)
Table 49. Emergent Biosolutions Company Detail
Table 50. Emergent Biosolutions Business Overview
Table 51. Emergent Biosolutions Biochemical Befense Product
Table 52. Emergent Biosolutions Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 53. Emergent Biosolutions Recent Development
Table 54. Hytest Company Detail
Table 55. Hytest Business Overview
Table 56. Hytest Biochemical Befense Product
Table 57. Hytest Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 58. Hytest Recent Development
Table 59. GSK Company Detail
Table 60. GSK Business Overview
Table 61. GSK Biochemical Befense Product
Table 62. GSK Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 63. GSK Recent Development
Table 64. Sanofi Company Detail
Table 65. Sanofi Business Overview
Table 66. Sanofi Biochemical Befense Product
Table 67. Sanofi Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. PharmAthene Company Detail
Table 70. PharmAthene Business Overview
Table 71. PharmAthene Biochemical Befense Product
Table 72. PharmAthene Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 73. PharmAthene Recent Development
Table 74. Bavarian Nordic Company Detail
Table 75. Bavarian Nordic Business Overview
Table 76. Bavarian Nordic Biochemical Befense Product
Table 77. Bavarian Nordic Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 78. Bavarian Nordic Recent Development
Table 79. SIGA Technologies Company Detail
Table 80. SIGA Technologies Business Overview
Table 81. SIGA Technologies Biochemical Befense Product
Table 82. SIGA Technologies Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 83. SIGA Technologies Recent Development
Table 84. Arbutus Biopharma Company Detail
Table 85. Arbutus Biopharma Business Overview
Table 86. Arbutus Biopharma Biochemical Befense Product
Table 87. Arbutus Biopharma Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 88. Arbutus Biopharma Recent Development
Table 89. DynPort Vaccine Company Detail
Table 90. DynPort Vaccine Business Overview
Table 91. DynPort Vaccine Biochemical Befense Product
Table 92. DynPort Vaccine Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 93. DynPort Vaccine Recent Development
Table 94. Xoma Corporation Company Detail
Table 95. Xoma Corporation Business Overview
Table 96. Xoma Corporation Biochemical Befense Product
Table 97. Xoma Corporation Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 98. Xoma Corporation Recent Development
Table 99. Ichor Medical Systems Company Detail
Table 100. Ichor Medical Systems Business Overview
Table 101. Ichor Medical Systems Biochemical Befense Product
Table 102. Ichor Medical Systems Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 103. Ichor Medical Systems Recent Development
Table 104. Aeolus Pharmaceuticals Company Detail
Table 105. Aeolus Pharmaceuticals Business Overview
Table 106. Aeolus Pharmaceuticals Biochemical Befense Product
Table 107. Aeolus Pharmaceuticals Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 108. Aeolus Pharmaceuticals Recent Development
Table 109. Achaogen Company Detail
Table 110. Achaogen Business Overview
Table 111. Achaogen Biochemical Befense Product
Table 112. Achaogen Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 113. Achaogen Recent Development
Table 114. Elusys Therapeutics Company Detail
Table 115. Elusys Therapeutics Business Overview
Table 116. Elusys Therapeutics Biochemical Befense Product
Table 117. Elusys Therapeutics Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 118. Elusys Therapeutics Recent Development
Table 119. Dynavax Technologies Company Detail
Table 120. Dynavax Technologies Business Overview
Table 121. Dynavax Technologies Biochemical Befense Product
Table 122. Dynavax Technologies Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 123. Dynavax Technologies Recent Development
Table 124. Cleveland BioLabs Company Detail
Table 125. Cleveland BioLabs Business Overview
Table 126. Cleveland BioLabs Biochemical Befense Product
Table 127. Cleveland BioLabs Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 128. Cleveland BioLabs Recent Development
Table 129. Soligenix Company Detail
Table 130. Soligenix Business Overview
Table 131. Soligenix Biochemical Befense Product
Table 132. Soligenix Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 133. Soligenix Recent Development
Table 134. Alnylam Pharmaceuticals Company Detail
Table 135. Alnylam Pharmaceuticals Business Overview
Table 136. Alnylam Pharmaceuticals Biochemical Befense Product
Table 137. Alnylam Pharmaceuticals Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 138. Alnylam Pharmaceuticals Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biochemical Befense Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Biochemical Befense Market Share by Type: 2022 VS 2029
Figure 3. Anthrax Features
Figure 4. Smallpox Features
Figure 5. Botulism Features
Figure 6. Radiation/Nuclear Features
Figure 7. Other Features
Figure 8. Global Biochemical Befense Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Biochemical Befense Market Share by Application: 2022 VS 2029
Figure 10. National Defense Case Studies
Figure 11. Military Case Studies
Figure 12. Biochemical Befense Report Years Considered
Figure 13. Global Biochemical Befense Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Biochemical Befense Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Biochemical Befense Market Share by Region: 2022 VS 2029
Figure 16. Global Biochemical Befense Market Share by Players in 2022
Figure 17. Global Top Biochemical Befense Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biochemical Befense as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Biochemical Befense Revenue in 2022
Figure 19. North America Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Biochemical Befense Market Share by Country (2018-2029)
Figure 21. United States Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Biochemical Befense Market Share by Country (2018-2029)
Figure 25. Germany Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Biochemical Befense Market Share by Region (2018-2029)
Figure 33. China Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Biochemical Befense Market Share by Country (2018-2029)
Figure 41. Mexico Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Biochemical Befense Market Share by Country (2018-2029)
Figure 45. Turkey Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Biochemical Befense Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Emergent Biosolutions Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 48. Hytest Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 49. GSK Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 50. Sanofi Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 51. PharmAthene Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 52. Bavarian Nordic Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 53. SIGA Technologies Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 54. Arbutus Biopharma Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 55. DynPort Vaccine Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 56. Xoma Corporation Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 57. Ichor Medical Systems Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 58. Aeolus Pharmaceuticals Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 59. Achaogen Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 60. Elusys Therapeutics Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 61. Dynavax Technologies Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 62. Cleveland BioLabs Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 63. Soligenix Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 64. Alnylam Pharmaceuticals Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 潰瘍性大腸炎治療オプションの世界市場2023年：抗炎症薬、免疫抑制剤、その他医薬品
  • トリメチルアミン尿症治療の世界市場2023年：経口、注射
  • 犬におけるレプトスピラ症治療の世界市場2023年：経口型、静脈注射型
  • ブロックチェーン・ファイナンスの世界市場2023年：ITソリューション、フィンテック、銀行、コンサルティング、取引所等
  • 原発性硬化性胆管炎（PSC）の世界市場2023年：医療、肝移植、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8523 )"生化学ベフェンスの世界市場2023年：炭疽菌、天然痘、ボツリヌス中毒症、放射線・核、その他" (英文：Global Biochemical Befense Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。